Ticker Details
BioAge Labs, Inc.
IPO Date:	September 26, 2024
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$789.52M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 3.38%
Avg Daily Range (30 D):	$0.71 | 3.68%
Avg Daily Range (90 D):	$0.66 | 3.88%

Institutional Daily Volume
Avg Daily Volume:	.39M
Avg Daily Volume (30 D):	.41M
Avg Daily Volume (90 D):	.55M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	163
Avg Institutional Trade:	$1.48M
Avg Institutional Trade (30 D):	$1.7M
Avg Institutional Trade (90 D):	$1.51M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$1.75M
Avg Closing Trade (90 D):	$1.41M
Avg Closing Volume:	118.72K

News

Jan 22, 2026 @ 3:30 AM BioAge Announces Pricing of Upsized $115.0 Million... Source: Not Specified

Jan 20, 2026 @ 9:01 PM BioAge Announces Proposed Public Offering Source: Globe Newswire

Jan 20, 2026 @ 2:00 PM BioAge Announces Indication Expansion for Oral NLR... Source: Bioage Labs, Inc.

Dec 13, 2025 @ 3:15 PM 2 Reasons I Wouldn't Touch BioAge Labs Stock With ... Source: Prosper Junior Bakiny

Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.24	$-.72	$-2.24
Diluted EPS	$-2.24	$-.72	$-2.24
Revenue	$9M	$3.08M	$9M
Gross Profit
Net Income / Loss	$-80.61M	$-25.94M	$-80.61M
Operating Income / Loss	$-92.78M	$-28.42M	$-92.78M
Cost of Revenue
Net Cash Flow	$-165.37M	$-26.67M	$-165.37M
PE Ratio